Status | Study |
Active, not recruiting |
Study Name: Treatment for Major Depressive Disorder With Intermittent Theta-burst Stimulation Condition: Depressive Disorder, Treatment-Resistant Date: 2022-04-13 Interventions: Interventional |
Active, not recruiting |
Study Name: An Epidemiology Study of Treatment Resistant Depression in the United States (US) Condition: Depressive Disorder, Treatment-Resistant Date: 2017-04-06 |
Recruiting |
Study Name: Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression Condition: Treatment Resistant Depression Date: 2017-03-01 Interventions: Drug: Monoamine Oxidase Inhibitor (MAOI) Monoamine Oxidase Inhibitor |
Recruiting |
Study Name: Accelerated Theta Burst in Treatment-Resistant Depression Condition: Treatment Resistant Depression Date: 2017-02-20 Interventions: Device: Active TBS-DLPFC |
Recruiting |
Study Name: Lithium Versus Quetiapine in Treatment Resistant Depression Condition: Depressive Disorder, Treatment-Resistant Date: 2016-11-17 Interventions: Drug: Quetiapine Quetipatine p |
Recruiting |
Study Name: A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression Condition: Depressive Disorder, Treatment-Resistant Date: 2016-04-29 Interventions: Drug: Intranasal Esketamine Open-Label Induction Phase: Participants will self-administer with esketamin |
Completed |
Study Name: Epidemiology of Treatment Resistant Depression in Taiwan Condition: Depressive Disorder, Treatment-Resistant Date: 2016-02-22 |
Recruiting |
Study Name: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression Condition: Depressive Disorder, Treatment-Resistant Date: 2015-11-17 Interventions: Drug: Ketamine |
Recruiting |
Study Name: A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression Condition: Treatment-resistant Depression Date: 2015-05-18 Interventions: Drug: Esketamine (Intranasal Spray) |
Recruiting |
Study Name: A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression Condition: Depressive Disorder, Treatment-Resistant Date: 2015-05-13 Interventions: Drug: Esketamine Open-label in |